Actemra (Tocilizumab) Utilization Among Pregnant Women

Project Title Actemra (Tocilizumab) Utilization Among Pregnant Women
Description

FDA required a pregnancy registry for Actemra (tocilizumab) when it was approved for RA. The sponsor is citing recruitment challenges given the limited use of Actemra in pregnant women.

Link
Published Date
Tuesday, July 18, 2017
Category
Modular Programs and Summary Tables